drugset / Trial / NCT04263402

The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia

NCT04263402

Phase 4 Unknown 100 enrolled Tongji Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

At present, there is no specific and effective antiviral therapy.In this study, an open, prospective/retrospective, randomized controlled cohort study was designed to compare the efficacy of different hormone doses in the treatment of 2019-nCoV severe Pneumonia.This study explores effective treatment programs for 2019-nCoV severe pneumonia and provides a reliable evidence-based basis for the treatment.

Timeline

Start
2020-02-01
Primary completion
2020-06-01
Completion
2020-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified Intravenous

Indications